Target Results

Together we can achieve our vision by eliminating HCV in Saudi Arabia by 2030. Together we can head to a brighter future by saving patient lives & resources. For more details about the benefits of achieving elimination vision, please check the following info


Reduction in HCV new cases1,2


Deaths to be avoided1,2

[10 Billion]

Saudi Riyals Costs savings1,2


Fewer cases of Hepatocellular Carcinoma1,2


Fewer cases of HCV-associated Cirrhosis1,2


Fewer cases of Decompensated Cirrhosis1,2

What could be done to help?

Explore Supporting Resources


1. Aljumah AA, Abaalkhail F, et al. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift. Saudi J Gastroenterol 2016;22:269‑81 2. Altraif I. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example. Saudi Medical Journal. 2018;39(8):842-845. 3. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. 4. Douglass CH, et al. BMC Med. 2018;16:175. doi:10.1186/ s12916-018-1162-z 5. Reau N, et al. Hepatol Commun. 2017;1:439–452. doi:10.1002/hep4.1049 6. Vietri J, et al. BMC Gastroenterol. 2013;13:16. doi:10.1186/1471-230X-13-16 7. Ghany MG, Strader DB, ThoHowlader N, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.mas DL, et al. Hepatology. 2009;49(4):1335–1374. EMCDDA Insights. Hepatitis C among drug users in Europe. 2016;

Approval Code: ABBV-SA-00012-MC

Copyright © 2021 AbbVie Inc. North Chicago, Illinois, U.S.A.